Tecan is proud to offer end-to-end cellomics workflow solutions, including cell seeding and culture with quality control and monitoring, through drug dosing to live-cell imaging and analysis. This ...
Cellomics, a unit of Fisher Biosciences, sponsors annual user group meetings in both the United States and Europe. The meetings bring together scientists from pharmaceutical and biotechnology ...
Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH have announced that they have entered into a worldwide, non-exclusive patent license agreement. The ...
The High End Cellomics Market is estimated to be valued at US$ 3.9 billion in 2023 and is expected to exhibit a CAGR of 12.7% over the forecast period 2023-2030, as highlighted in a new report ...
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "High-end Cellomics - Analysis, Outlook, Growth, Trends, Forecasts 2021-2031" report has been added to ResearchAndMarkets.com's offering. This report on ...
Cellomics Inc. reached agreements to license its life sciences technology to GE Healthcare, the Pittsburgh company said Tuesday. The non-exclusive, worldwide agreement allows GE Healthcare, a $14 ...
RESEARCH TRIANGLE–Norak and Cellomics of Pittsburgh said they will jointly market Norak’s Transfluor licenses in North America and Europe. Norak’s Transflour technology is a patented drug discovery ...
Cellomics Inc along with the Defense Advanced Research Projects Agency (DARPA) has developed a benchtop system that utilizes living cells for the detection, classification and identification of ...
In a series of moves aimed at refocusing its resources on commercialization, Cellomics Inc. of Pittsburgh has reorganized its board and cut its staff in half, according to chairman and CEO D. Lansing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results